Kathy A. Steece-Collier, Ph.D.

Affiliations: 
Translational Science & Molecular Medicine Michigan State University, East Lansing, MI 
Area:
Parkinson's disease / dyskinesias / synaptic reorganization
Google:
"Kathy Steece-Collier"
Mean distance: 16.92 (cluster 6)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Patterson JR, Hirst WD, Howe JW, et al. (2022) Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. Npj Parkinson's Disease. 8: 61
Caulfield ME, Stancati JA, Steece-Collier K. (2021) Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease. Journal of Visualized Experiments : Jove
Cole TA, Zhao H, Collier TJ, et al. (2021) α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease. Jci Insight. 6
Miller KM, Patterson JR, Kochmanski J, et al. (2021) Striatal afferent BDNF is disrupted by synucleinopathy and partially restored by STN DBS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Mercado NM, Stancati JA, Sortwell CE, et al. (2020) The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in rats. Neurobiology of Disease. 105175
Bartlett MJ, Flores AJ, Ye T, et al. (2020) Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia. Experimental Neurology. 113413
Steece-Collier K, Collier TJ, Lipton JW, et al. (2020) Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in fisher 344 vs. Lewis hemiparkinsonian rats. Experimental Neurology. 113327
Sellnow RC, Steece-Collier K, Altwal F, et al. (2020) Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Collier TJ, Sortwell CE, Mercado NM, et al. (2019) Cell therapy for Parkinson's disease: Why it doesn't work every time. Movement Disorders : Official Journal of the Movement Disorder Society
Steece-Collier K, Stancati JA, Collier NJ, et al. (2019) Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society
See more...